Prostate-Specific AntigenProstateProstatic NeoplasmsProstatic HyperplasiaProstatectomyAntigensDigital Rectal ExaminationAzasteroidsBiopsy, NeedleAndrogen AntagonistsAntigens, NeoplasmProstatic DiseasesAntigens, BacterialTumor Markers, BiologicalReceptors, AndrogenNational Cancer Institute (U.S.)BiopsyWatchful WaitingSensitivity and SpecificityAntibodies, ImmobilizedAntigens, SurfaceAndrogensAdenocarcinomaMass ScreeningAllylestrenolTissue KallikreinsAntigens, ViralNeoplasm Staging5-alpha Reductase InhibitorsProstatitisAndrogen Receptor AntagonistsFlutamideBrachytherapyFinasterideEnzyme PrecursorsSeminal Vesiclesalpha 1-AntichymotrypsinProstatic Intraepithelial NeoplasiaImmunoassayOrchiectomyPrognosisTime FactorsCell Line, TumorEarly Detection of CancerTestosteroneSemenLeuprolideEarly DiagnosisDihydrotestosteronePredictive Value of TestsBone NeoplasmsNeoplasm GradingDisease ProgressionAntigens, ProtozoanUnnecessary ProceduresImmunohistochemistryKallikreinsArea Under CurveNeoplasm Recurrence, LocalProtein Array AnalysisAntigens, HelminthROC CurveAntigens, FungalProbabilityRetrospective StudiesAntigens, Polyomavirus TransformingCarcinomaEpitopesTumor Cells, CulturedAge FactorsRegression AnalysisCohort StudiesAntigens, CDAntibodies, MonoclonalProspective StudiesCancer Care FacilitiesAntineoplastic Agents, HormonalHLA AntigensObservationCase-Control StudiesT-LymphocytesNeoplasm MetastasisMultivariate AnalysisRisk AssessmentBaltimoreRisk FactorsBiological MarkersReference ValuesFollow-Up StudiesReceptors, Antigen, T-CellH-2 AntigensEnzyme-Linked Immunosorbent AssayReproducibility of ResultsBiosensing TechniquesCell ProliferationLymphocyte ActivationAntigen-Antibody ReactionsConfidence IntervalsMice, Inbred BALB CImmunoglobulin G